(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 5. Myosin II and Myosin VI act at distinctive steps in the same pathway to localize Miranda. Live imaging of embryos co-expressing Miranda-GFP (green) and Histone2A-mRFP (red) injected with buffer as a control (A), a Rho kinase inhibitor to downregulate Myosin II (B), treated by MyoVI RNAi (C), or both RKI and MyoVI RNAi (D). After injections, embryos were fixed and stained with anti-Miranda antibody (green). DNA, red.